Featured Articles
Read our latest stories on the people and scientific innovations making a difference in patients’ lives.
Real People
Advocacy, Strength, and Hope in the Face of Metastatic Melanoma: Bruce and Chris's Story
In 2013, Bruce’s life changed. He was living in sunny Florida with Chris, his wife of over 20 years, when he received an unexpected diagnosis: metastatic melanoma—the most aggressive form of skin cancer.1,2It was a disease Bruce had heard of before—a disease that will impact over 100,000 people in the U.S. this year and 510,000 people across the world by 2040.2,3 But it didn’t cross his mind when he noticed a small lesion on the top of his foot. Chris encouraged Bruce to get it checked out. In...
Programs & Initiatives
Why Partnerships Are Vital in the Post-Emergency COVID-19 Era
In May 2023, while acknowledging that COVID-19 remains an ongoing and serious public health priority, the World Health Organization (WHO) and U.S. Department of Health and Human Services (HHS) announced that COVID-19 was no longer a public health emergency.1,2“While the worst impacts of the pandemic may be behind us, ending public health emergencies does not mean COVID-19 is no longer a threat,” says James Allen, Head of Customer and Channel Partnerships in Pfizer's U.S. Primary Care Business.In...
Trusted Voices
Together We Can Change the Odds for People with Cancer
One in three people in the United States will receive a cancer diagnosis in their lifetime.i This means you, or someone you know, may someday be impacted. This disease does not discriminate. Unfortunately, many people face unnecessary barriers to timely and equitable screening, treatment and support. To help close these gaps, the American Cancer Society (ACS) and Pfizer recently launched a new three-year initiative, “Change the Odds: Uniting to Improve Cancer Outcomes,” aimed at addressing...
Real People
Got Yours? Spokesperson Martha Stewart on Health and Wellness
Martha Stewart has seemingly done it all – she’s a lifestyle expert, media mogul, and even founded a care center to support the geriatric population.She recently chatted with Pfizer.com about why she joined the Got Yours? COVID-19 vaccination campaign, how her father’s job at Pfizer impacted her view on science, how she juggles her busy schedule and more!Pfizer: The first thing we wanted to ask you is why you chose to partner with Pfizer, and if you've had a favorite part of being involved in...
Living & Wellbeing
Severe COVID-19 and the Continuing Importance of Protecting High Risk Populations
The concept of "severe COVID-19" can be a frightening one, especially when the term itself is so often misunderstood or confused with having self-assessed severe symptoms of COVID-19.Approximately 80% of those who test positive for COVID-19 have mild to moderate illness.1 But adults 50 and older and people of any age with certain underlying health conditions are at high risk of progression to severe COVID-19. That adds up to two in five people worldwide who are at increased risk for severe COVID...
Programs & Initiatives
The Future of Pharmacovigilance: Monitoring Medicine and Vaccine Safety Using AI and Other Tech
While many Pfizer colleagues worked to, develop and manufacture a vaccine for COVID-19, one Pfizer team was hard at work monitoring the safety of the COVID-19 vaccine trial. And they did so while also maintaining safety monitoring operations for more than 1,000 other products in the Pfizer portfolio.Pharmacovigilance is the name for the area of science which scientists and medical professionals monitor medicine and vaccine-related safety issues. “Medicine and vaccine safety is one of those...
Programs & Initiatives
The Importance of Returning Clinical Trial Data to Participants
Clinical trial participants are at the heart of medical research, and it’s with their help that Pfizer is able to bring life-changing treatments to patients. But, until recently, clinical trial sponsors like Pfizer have not been equipped to provide participants with their own personal clinical trial data when a trial ends. Pfizer’s team of clinical trial experts have worked for many years to change that by launching the Clinical Trial Participant Data Return Initiative. This first-of-its...
Science & Innovation
Mathematical Sandbox: How Quantitative Systems Pharmacology Steers Safer, Faster Drug Development
Fear and anxiety swirled when Dr. Cynthia J. Musante’s husband contracted COVID-19. He faced a greater risk of coming down with a severe case since he was already unwell. But all their worries vanished in just 24 hours. Dr. Musante recalls that her husband soon started to feel better after being prescribed an investigational oral treatment for those with COVID-19. “It felt like a miracle,” he said. “I had felt so horrible.” As relief settled in, Dr. Musante felt something else...
Science & Innovation
From Math to Medicine: What Are Mathematical Models and How Do They Predict Pharmacology?
It sounds strange, but predicting how medications impact diseases and the body is a lot like forecasting the weather. To understand why, imagine opening a weather app on your smartphone to check the forecast for the upcoming weekend. You see that it’ll be sunny, 72 degrees, with a slight breeze—perfect weather. But how did scientists predict those precise physical conditions so far in the future? The answer: mathematical models. Scientists across disciplines use mathematical models to...
Purpose & Ideals
Cancer Survivors' 'Butterfly Club' Network Fosters Support and Partnership
For many cancer survivors, life splits into two stages: before cancer and after cancer. That’s been the case for Lynette Bojko, Pfizer’s Head of Strategic Sourcing & Business Management. She was diagnosed with breast cancer just before her 40th birthday. “Unfortunately or fortunately, cancer is a lot of my identity,” she says. When treatment began, she didn’t want to hide what she was going through at the office, so she talked about it. That openness allowed her to connect with colleagues...
Real People
The Butterfly Club: Stories of Volunteers that Colleagues with Cancer Can Lean On
When Nikki Shaffer was diagnosed with breast cancer at 35, she had so many questions. How should she tell her three young children about it? Should she keep working? Would she see her kids grow up? That was in 2009. As Shaffer went through treatment, a non-profit connected her with other cancer survivors, but she didn’t click with anyone. “They connected me to people who were in their 50s when they were diagnosed, and their questions and their concerns were not the same as mine,” says Shaffer...
Living & Wellbeing
Adolescents with Alopecia Areata: What Caregivers Should Know
A lot of kids just want to fit in.1 But for too many, hair loss makes them stand out. For the one in 1,000 children and teens diagnosed with alopecia areata (AA), an autoimmune disease that causes the immune system to attack the hair follicles, hair loss can create practical challenges.2,3 Youth with AA might feel too self-conscious for selfies, refuse to go out without a hat, or decline invitations to swimming parties or sports leagues for fear their wigs will fall off. In a 2017 study of 69...
Media Resources & Contact Information
Anyone may view our press releases, press statements, and press kits. However, to ensure that customers, investors, and others receive the appropriate attention, Pfizer Media Contacts may only respond to calls and emails from professional journalists.